Drug Database
KE

ketoprofen spray

✓ Approved

Giuliani · PTGS1 · 小分子

什么是 ketoprofen spray?

ketoprofen spray 是一种小分子,由Giuliani研发。该药已获批,用于治疗相关适应症,给药途径:Transdermal。

药物档案

公司Giuliani
药物类别小分子
分子靶点PTGS1, PTGS2
给药途径Transdermal
状态Approved

作用机制

分子靶点

ketoprofen spray 作用于 2 个分子靶点:

PTGS1prostaglandin-endoperoxide synthase 1 (COX3, PCOX1)
PTGS2prostaglandin-endoperoxide synthase 2 (GRIPGHS, hCox-2)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

ketoprofen spray 针对 2 个适应症,涉及 2 个治疗领域。

治疗领域疾病/病症分期
Hepatobiliary disordersHepatitis✓ Approved
Musculoskeletal and connective tissue disordersMusculoskeletal pain✓ Approved

相关研究文献

PubMedAJE advances : research in epidemiology2026-11-19

Can self- or caregiver-administered nasal spray influenza vaccination improve outcomes? An agent-based model using the framework for reconstructing epidemiological dynamics.

Williams Katherine V KV, Nowalk Mary Patricia MP, Krauland Mary G MG, Mandell Alexis J AJ et al.

Newly licensed self- or caregiver-administered nasal spray live attenuated influenza vaccine (LAIV), available to order for home delivery, may improve vaccination coverage (VC) among adults aged 18-49 overall, as well as among those in this age group who live in households with school-aged children. Using the agent-based Framework for Reproducing Epidemiological Dynamics, which simulates influenza transmission in US census-based populations with defined household structures, we modeled the impact of: (1) 5%-15% VC increase among those aged 18-49 through self-administration and (2) household-based strategies for ages 5-17 and 18-49 that may occur from home LAIV orders. The household strategies included vaccinating children aged 5-17, followed by their 18-49-year-old head of household (HH) (kids + HH), and vaccinating children aged 5-17 and all household adults aged 18-49 (kids + adults). A 5%-15% VC increase in adults aged 18-49 reduced symptomatic cases in all adults by up to 10%. Among household strategies, kids + adults yielded a higher VC increase (9.2%) and greater reduction in symptomatic cases (5.7%) among adults ≥18 than the kids + HH strategy. The convenience of self-administration and household-based LAIV strategies in homes with school-age children may enhance adult VC and reduce influenza burden.

PMID 43053808
阅读全文 →
PubMedClinical ophthalmology (Auckland, N.Z.)2026-11-18

Varenicline Nasal Spray for Signs and Symptoms of Dry Eye Disease Associated with Meibomian Gland Dysfunction: A Retrospective Study.

Zhang Yi-Jia YJ, Wang Gong-Yue GY, Tang Xue-Li XL, Xiao Yu-Ting YT et al.

To evaluate short-term post-dose and 4-week clinical changes in patients treated with varenicline nasal spray for dry eye disease (DED) associated with meibomian gland dysfunction (MGD). This retrospective study included 26 patients (26 eyes) with DED associated with MGD who received varenicline nasal spray between July and December 2025. Short-term post-dose changes were assessed by comparing measurements obtained before and 10 minutes after a single dose on Day -1. At least 24 hours later, Day 0 served as the longitudinal baseline, after which patients received one spray containing 0.03 mg in each nostril twice daily for 4 weeks. Outcomes included symptoms, tear-film parameters, corneal staining, meibomian gland measures, and the density of conjunctival goblet-cell-like structures assessed by in vivo confocal microscopy (IVCM). At 10 minutes post-dose, lipid layer thickness (LLT), non-invasive tear film break-up time (NIBUT), tear meniscus height, and anesthetized Schirmer test scores increased significantly (all P < 0.0001). At Week 4, mean paired changes were -21.43 points for OSDI (95% CI, -24.97 to -17.90), 28.19 nm for LLT (95% CI, 21.31-35.07), and 6.29 seconds for NIBUT (95% CI, 4.40-8.18; all P < 0.0001). Meibomian gland yielding scores increased and secretion scores decreased (both P < 0.0001), whereas gland dropout rates remained unchanged. IVCM-derived goblet-cell-like density increased by 138.04 cells/mm2 (95% CI, 105.62-170.45; P < 0.0001). No serious adverse events were documented; three patients experienced mild, transient nasal events. During 4 weeks of varenicline nasal spray treatment, improvements in dry eye symptoms, tear-film parameters, corneal staining, and meibomian gland functional measures, together with an increase in IVCM-observed conjunctival goblet-cell-like structures, were observed. These exploratory findings require confirmation in prospective, controlled, and longer-term studies.

PMID 43048565
阅读全文 →
PubMedJournal of the science of food and agriculture2026-11-18

Correction to 'Application of soy protein isolate-xylose conjugates for improving the viability and stability of probiotics microencapsulated by spray drying'.

PMID 43049540
阅读全文 →
PubMedVestnik otorinolaringologii2026-11-18

[Topical therapy in the treatment of chronic unilateral rhinosinusitis: rationale for use and study results].

Karpishchenko S A SA, Karpishchenko E S ES, Brigalyan A T AT

To evaluate the clinical efficacy of Polydexa with phenylephrine (Polydexa with PE) nasal spray as part of combination therapy for patients with chronic unilateral rhinosinusitis both in the postoperative period and during conservative treatment for disease exacerbation compared to control groups that did not receive the drug. A retrospective-prospective study included 30 patients (16 males and 14 females) aged 22 to 80 years with chronic unilateral paranasal sinusitis who were treated at the Otolaryngology Clinic of the Pavlov First Saint Petersburg State Medical University from October 2024 to January 2026. Surgical treatment was given to 18 patients, and conservative treatment - to 12 subjects. In each group, patients were further divided into a study group (systemic antibacterial and irrigation therapy in combination with Polydexa with PE nasal spray) and a control group (only systemic antibacterial and irrigation therapy). The assessment was performed using a visual analogue scale (VAS, 0-10 points), the Lund-Kennedy endoscopic scoring system, and the SNOT-20 questionnaire before treatment and on days 3, 7 and 14 after its initiation. With comparable baseline parameters (p>0.05), patients in the conservative treatment subgroup treated with Polydexa with PE nasal spray demonstrated faster pain regression according to the VAS at most observation time points. Furthermore, these subjects showed a statistically significantly faster regression of endoscopic changes according to the Lund-Kennedy scale from day 3 of therapy (p<0.05 in both groups on days 3, 7, and 14) and faster improvement in quality of life according to the SNOT-20 questionnaire (p<0.05 from day 3 in operated patients and from day 7 in non-operated subjects). Of those receiving conservative treatment, patients in the study group achieved a 50% reduction in pain according to the VAS and SNOT-20 on average 4 and 4.7 days earlier than subjects in the control group (p=0.001 and p=0.025, respectively). The mean time to normalization of endoscopic findings (reduction of the Lund-Kennedy score to ≤1) was 10.1±3.7 days in the study group of operated patients compared to 14 days in the control group (p=0.012). The use of Polydexa with PE nasal spray as part of combination therapy for patients with chronic unilateral rhinosinusitis both in the postoperative period and during conservative management is accompanied by a more rapid regression of clinical symptoms and improvement in the endoscopic picture of the nasal mucosa. These results justify recommending Polydexa with PE for the management of this pathology.

PMID 43046750
阅读全文 →
PubMedAnalytical chemistry2026-11-18

Induced Nanoelectrospray Ionization for Spontaneous Singlet Oxygen Formation and Oxidative Transformation of Pollutants.

Zhang Min M, Yuan Feng F, Li Sining S, Leng Yuxin Y et al.

Induced nanoelectrospray ionization (induced nESI) is a noncontact, in situ spray methodology initiated by an externally applied high-voltage electric field. Within this setup, the mass spectrometer serves as a counter electrode that shapes the electric-field distribution and governs charge transport via electrostatic induction, thereby sustaining a stable spray containing positive and negative ions. Notably, the rapid transition from bulk solution into highly charged microdroplets triggers the spontaneous, in situ generation of singlet oxygen (1O2) at the μg mL-1 level, providing the first experimental evidence of spontaneous 1O2 generation within an induced nESI source. Mass spectrometric analysis confirmed this selective 1O2-mediated oxidation, revealing the characteristic signals of 9,10-diphenylanthracene oxidation products with a mass increase of 32 Da. 1O2 formation was further validated using multiple chemical probes, including 1,5-dihydroxynaphthalene, 1,3-diphenylisobenzofuran, and furfuryl alcohol, complemented by deuterium oxide-induced lifetime enhancement and radical-trapping experiments. Leveraging this highly selective oxidation mechanism, this platform enables the efficient transformation of six representative organic pollutants, including dibenzo-p-dioxin and bisphenol A. Collectively, these results establish induced nESI as a powerful new analytical and reaction platform for advanced oxidation processes.

PMID 43046373
阅读全文 →
PubMedElectrophoresis2026-11-18

On-Column Focusing Strategies for Large-Volume Injections in Nano-Liquid Chromatography: Sample Diluent, Injection Sequence, and Localized Cooling.

D'Orazio Giovanni G, Fanali Salvatore S

Sensitivity remains a major limitation of nano-liquid chromatography (nano-LC), where reduced injection volumes and small spectrophotometric detection cells constrain analytical performance relative to conventional HPLC. This work systematically investigated sample on-column focusing strategies to control overloading during large-volume injections in nano-LC without compromising chromatographic resolution and efficiency. Using a model mixture of alkylbenzenes separated on a 100 µm i.d. capillary column packed with a C18 stationary phase in a lab-made nano-LC system, three complementary approaches were evaluated: (i) tuning the sample diluent composition, including aqueous content and the use of conventional and green organic co-solvents (isoamylacetate, 2-methyltetrahydrofuran, and dimethyl carbonate); (ii) injection-sequence strategies based on pre- and post-injection solvent plugs; and (iii) localized low-temperature focusing achieved with an instant cold spray applied at the column inlet immediately before sample injection. Optimizing diluent composition alone enabled a ∼40/60-fold increase in injection volume (up to 600-1000 nL) without loss of efficiency. Adding a post-injection water plug extended this to ∼120/150-fold (2000-2500 nL), improving chromatographic efficiency by up to 30%. When high diluent eluent strength precluded solvent-based focusing, a brief cold-spray application at the column inlet (down to ∼4°C) fully restored resolution, independent of the organic solvent used. These results demonstrate that combining diluent tuning, injection-sequence control, and low-temperature focusing can extend nano-LC injection volumes by nearly two orders of magnitude beyond the theoretical admissible injection volume while preserving separation performance, offering simple, low-cost strategies to improve analytical sensitivity.

PMID 43049569
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多ketoprofen spray